Artificial intelligence (AI) tools can help physicians predict treatment and survival outcomes in patients with advanced ...

Artificial intelligence (AI) tools can help physicians predict treatment and survival outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with immunotherapy, according to a ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers such as ...

Drugs called CDK2 inhibitors, which are currently being tested as treatments to slow the growth of a narrow range of cancers, ...

Lung cancer is classified into non-small cell and small cell types, influencing treatment strategies and prognosis. Advances in targeted therapies, immunotherapy, and minimally invasive surgeries have ...

David DiBardino, MD, explains why intratumoral therapy emerged in lung cancer and the open questions in standardizing how ...

Dublin, July 09, 2026 (GLOBE NEWSWIRE) -- The "Lung Cancer Therapeutics: Global Markets" has been added to ResearchAndMarkets.com's offering. The global market for lung cancer therapeutics is poised ...

The trial will be conducted across the U.S. and will be the first prospective human study to test a treatment specifically ...